US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 278 actively recruiting studies with Colorado sites out of 278 registered in total. The busiest research areas in Colorado are Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung. Leading sponsors running trials in the state include University of Colorado, Denver, Merck Sharp & Dohme LLC, National Cancer Institute (NCI). By stage, Colorado trials break down as Phase 1 (53), Phase 2 (84), Phase 3 (71), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
278
Recruiting Now
278
← Back to US Map
Top Conditions in Colorado
Advanced Solid Tumor (5)Breast Cancer (4)Carcinoma, Non-Small-Cell Lung (4)Malignant Neoplasm (3)Multiple Myeloma (3)B Acute Lymphoblastic Leukemia (3)Metastatic Breast Cancer (3)Kidney Diseases (3)Pancreatic Ductal Adenocarcinoma (3)Pulmonary Hypertension (3)Alzheimer Disease (3)Type 1 Diabetes (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 278 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 278. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT04889872 N/A
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAV...
Condition
Aortic Stenosis, Calcific
Enrollment
2,250 pts
Location
United States, Australia, Canada
Sponsor
Edwards Lifesciences
View Trial →
NCT06788912 Phase 2
Recruiting
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell...
Condition
Lung Neoplasm Malignant
Enrollment
60 pts
Location
United States, Chile, Greece
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04457154 N/A
Recruiting
Pediatric Post-Approval Registry
Condition
Obstructive Sleep Apnea
Enrollment
60 pts
Location
United States
Sponsor
Inspire Medical Systems, Inc.
View Trial →
NCT03606967 Phase 2
Recruiting
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
86 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07043400 Phase 3
Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versu...
Condition
Metastatic Gastric Adenocarcinoma
Enrollment
351 pts
Location
United States, Argentina, Austria
Sponsor
BeOne Medicines
View Trial →
NCT06810622 N/A
Recruiting
NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Condition
Kidney Diseases
Enrollment
448 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT03674372 N/A
Recruiting
Fetoscopic Endoluminal Tracheal Occlusion
Condition
Congenital Diaphragmatic Hernia
Enrollment
10 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06001788 Phase 1
Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Ref...
Condition
AML
Enrollment
171 pts
Location
United States, Italy, Spain
Sponsor
Kura Oncology, Inc.
View Trial →
NCT07221253 Phase 3
Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatmen...
Condition
Biliary Tract Cancer
Enrollment
1,100 pts
Location
United States, Australia, Belgium
Sponsor
AstraZeneca
View Trial →
NCT06578195 N/A
Recruiting
ASSESS ALL ALS Study
Condition
Amyotrophic Lateral Sclerosis
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
St. Joseph's Hospital and Medi
View Trial →
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
View Trial →
NCT06084481 Phase 1
Recruiting
Study to Assess Adverse Events and Change in Disease Activity in Adult Participa...
Condition
Hepatocellular Carcinoma
Enrollment
325 pts
Location
United States, Australia, Israel
Sponsor
AbbVie
View Trial →
NCT06964087 Phase 2
Recruiting
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Me...
Condition
Type I Diabetes
Enrollment
72 pts
Location
United States
Sponsor
Op-T LLC
View Trial →
NCT06797999 Phase 1, Phase 2
Recruiting
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Condition
Metastatic Soft Tissue Sarcoma
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Adcendo ApS
View Trial →
NCT07205341 N/A
Recruiting
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
Condition
Aortic Valve Stenosis
Enrollment
20 pts
Location
United States
Sponsor
HemoCept Inc.
View Trial →
NCT05267821 Phase 2, Phase 3
Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Condition
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Enrollment
500 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT06561685 Phase 1
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Condition
Metastatic Solid Tumor
Enrollment
340 pts
Location
United States, France, Germany
Sponsor
Eli Lilly and Company
View Trial →
NCT06747117 N/A
Recruiting
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus ...
Condition
Lower Extremity Acute Limb Ischemia
Enrollment
300 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
View Trial →
NCT04718168 N/A
Recruiting
GORE® ENFORM Biomaterial Product Study
Condition
Hernia, Ventral
Enrollment
245 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT06686394 Phase 1, Phase 2
Recruiting
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With...
Condition
Breast Neoplasms
Enrollment
81 pts
Location
United States, Canada, Israel
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT04817618 Phase 3
Recruiting
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Condition
C3G
Enrollment
98 pts
Location
United States, Argentina, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06515613 Phase 1
Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other A...
Condition
Platinum-resistant Ovarian Cancer
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Context Therapeutics Inc.
View Trial →
NCT06359041 Phase 1, Phase 2
Recruiting
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participant...
Condition
Generalized Myasthenia Gravis (gMG)
Enrollment
24 pts
Location
United States
Sponsor
Cabaletta Bio
View Trial →
NCT05677880 N/A
Recruiting
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoence...
Condition
CADASIL
Enrollment
660 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
Page 7 of 12 — 278 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology